Status:
COMPLETED
Improving Outcomes for Hypertensive Children
Lead Sponsor:
Arkansas Children's Hospital Research Institute
Conditions:
Hypertension
Eligibility:
All Genders
6-17 years
Brief Summary
Approximately 200 children age 6 - \<18 years receiving medications for essential hypertension (HTN) will be recruited from the Pediatric Hypertension Clinic at the time of a routine clinic visit. Par...
Eligibility Criteria
Inclusion
- Age 6-17 years (up to 18th birthday) receiving anti-hypertensive medication(s) by subject history at presentation for the qualifying clinic visit
- Arm circumference measurement of 15-50 cm (limits of SpaceLabs ABPM cuffs).
Exclusion
- Severe HTN which in the opinion of the treating physician would prevent the subject from delaying changes in therapy to complete the study.
- Secondary HTN from all causes (excluding obesity-related HTN). This includes but is not limited to renovascular HTN, chronic kidney disease, coarctation of the aorta, and monogenic forms of HTN.
- Physical limitations prohibiting placement of the ABPM monitor.
- Significant arrhythmias or known disruptions in cardiac output which may interfere with the monitor's ability to detect BP accurately.
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2015
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT01485783
Start Date
November 1 2011
End Date
May 1 2015
Last Update
September 10 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Arkansas Children's Hospital
Little Rock, Arkansas, United States, 72212